Cigna Corp. (CI) Misses Q2 EPS Views; Updates FY16 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq rise in choppy trading as tech steadies, Micron results in focus
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Leerink Partners Cuts Price Target on Cigna Corp. (CI) to $155 Following 2Q Miss
August 1, 2016 10:10 AM EDTLeerink Partners maintained an Outperform rating on CIGNA (NYSE: CI), and cut the price target to $155.00 (from $160.00), following the company's 2Q earnings report. The company reported an EPS miss of 39c and $1.20 guide-down driven mostly by Group Life & Disability but to a lesser extent Global Healthcare.
Analyst Ana Gupte commented, "We revise our CI 2017E and 2018E EPS to $9.50 & $10.88 after a surprise miss and guide-down on Disability & Life as well as a smaller miss in Healthcare. The miss in... More
